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Abstract Orthostatic hypotension (OH) is associated with
increased total mortality but contribution of speciﬁc death
causes has not been thoroughly explored. In this prospective
study, authors followed up 32,068 individuals without
baseline history of cancer or cardiovascular disease (69%
men; mean age, 46 years; range, 26–61 years) over a period
of 24 years. Hazard ratios (HRs) for total and cause-speciﬁc
mortality associated with presence of OH and by quartiles
of postural systolic blood pressure response (DSBP) were
assessed using multivariate adjusted Cox regression model.
A total of 7,145 deaths (22.3%, 9.4 deaths/1,000 person-
years) occurred during follow-up. Those with OH (n =
1,943) had higher risk of death due to injury (HR, 1.88;
1.37–2.57) and neurological disease (HR, 2.21; 1.39–3.51).
Analogically, risk of death caused by injury and neurolog-
ical disease increased across the quartiles of DSBP
from hyper- (Q1SBP, ?8.5 ± 4.7 mmHg) to hypotensive
response (Q4SBP, -13.7 ± 5.7 mmHg; HR, 1.32;
1.00–1.72, and 1.84; 1.20–2.82, respectively) as did also
risk of death due to respiratory disease (Q4SBP vs. Q1SBP:
HR, 1.53; 1.14–2.04). In contrast, risk curve for cerebro-
vascular death was U-shaped with nadir in the mildly
hypotensive 3rd quartile of DSBP (-5.0 ± 0.1 mmHg,
Q3SBP vs. Q1SBP: HR, 0.75; 0.54–1.03; P for linear
trend = 0.021). Additionally, cardiovascular mortality
was increased among 5,805 rescreened participants (mean
age, 53 years; 9.8% OH positive: HR, 1.54; 1.24–1.89, and
Q4SBP vs. Q1SBP: 1.27; 1.02–1.57, respectively). In sum-
mary, increased mortality predicted by blood pressure fall
on standing is associated with injuries, neurodegenerative,
and respiratory diseases, as well as with cardiovascular
disease in older adults. Moreover, both increase and pro-
nounced decrease of SBP during early orthostasis indicate
higher risk of cerebrovascular death.
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Abbreviations
OH Orthostatic hypotension
MPP Malmo ¨ Preventive Project
CVD Cardiovascular disease
BMI Body-mass index
SBP Systolic blood pressure
DBP Diastolic blood pressure
ICD International Classiﬁcation of Diseases
IHD Ischaemic heart disease
COPD Chronic obstructive pulmonary disease
Introduction
Orthostatic hypotension (OH), a relatively common mani-
festation of autonomic dysfunction [1–3], has been linked
to increased mortality in general population [4–8].
Although it seems indisputable that OH is associated with
higher all-cause mortality, speciﬁc causes of death have
been only partially studied. In particular, Rose et al. [6]
noticed that OH predicted both higher cardiovascular and
non-cardiovascular mortality, but not cancer-related one.
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were not explored. In parallel, authors reported that
younger (\42 years) compared to older individuals with
OH demonstrated a higher all-cause mortality risk, but the
risk of incident coronary event and stroke was not
increased in this subset of population [8].
Previous epidemiological studies concentrated mainly
upon OH as a pronounced and well-deﬁned variant of the
hypotensive postural blood pressure response [9]. Mean-
while, it is still unknown which mortality pattern is fol-
lowed by other types of orthostatic responses: mildly
hypotensive, neutral and hypertensive. Consequently,
authors decided to study speciﬁc causes of death among
those with and without OH, as well as in the subsets of
different postural blood pressure responses within a large
middle-aged Swedish population.
Methods
Study population
The Malmo ¨ Preventive Project (MPP) is a population-
based prospective cohort study in the city of Malmo ¨,i n
southern Sweden [10]. The primary aim of the project was
to invite large strata of the adult population to screening for
cardiovascular disease (CVD). A total of 33,346 (22,444
men and 10,902 women; mean age, 45 years; range,
26–61 years) inhabitants of Malmo ¨, born between 1921
and 1948, were examined between 1974 and 1992. The
overall attendance rate was 71% (range for examined age
cohorts, 64–78%) [11]. In the present study we excluded
549 participants because of missing blood pressure values,
eight outliers (difference between systolic or diastolic
blood pressure in supine and standing position of more than
80 mmHg), and all individuals with baseline history of
CVD (myocardial infarction or stroke, n = 159) or cancer
(n = 562). Thus, the study population consisted of 32,068
individuals (22,130 men and 9,938 women). An overall
study design is presented in Fig. 1.
Baseline examination
The mailed invitation contained instructions to abstain
from food, alcohol and tobacco for 12 h prior to the
examination, which was performed by trained nurses in the
morning. Participants were, however, allowed to drink
water ad libitum. Blood pressure was measured using the
auscultatory method with a mercury sphygmomanometer
and an appropriately sized cuff placed around the right arm
supported at the level of the heart. The ﬁrst blood pressure
reading was taken twice after 10 min rest in the supine
position. Then, the participants were asked to stand up and
the second blood pressure measurement was taken twice in
the standing position between 1 and 3 min of standing. The
mean value of two readings was recorded for each position
and rounded to nearest 5 mmHg. The body-mass index
(BMI) was calculated as weight in kg divided by height
squared in meters. Blood samples were collected from the
antecubital vain and analyzed by standard methods at the
Department of Clinical Chemistry, Malmo ¨ University
Hospital. At the end, the participants were asked to ﬁll in a
self-administered questionnaire focused on personal and
familiar history of CVD, hypertension, diabetes, cancer,
smoking habits, and lifestyle patterns. The following
questions were relevant to the history of myocardial
infarction, stroke, and cancer, if the answer was yes: ‘‘Have
you ever been hospitalized for myocardial infarction/
stroke?’’ or ‘‘Have you ever had/do you have cancer?’’
Antihypertensive treatment was deﬁned as a positive
answer to the following question: ‘‘Do you take medication
for high blood pressure?’’, but data on particular types of
antihypertensive agents were not collected. Those who
conﬁrmed regular or occasional current smoking were
classiﬁed as smokers. Alcohol intake was dichotomized by
drinking behavior (problematic, non-problematic), and
socioeconomic status was divided into low (manual
worker) and high (non-manual worker) according to pre-
viously applied method [12]. A detailed description of
recruitment and screening procedures may be found else-
where [10, 13]. The health service authority of Malmo ¨
approved and funded the screening program. All partici-
pants gave informed consent.
Deﬁnitions of clinical characteristics
OH was deﬁned according to the international consensus
criteria as a decrease in systolic blood pressure (SBP)
C20 mm Hg and/or decrease in diastolic blood pressure
(DBP) C10 mm Hg within three minutes of standing [14].
Orthostatic (postural) SBP response (DSBP) was deﬁned
as standing SBP—supine SBP. Diabetes was deﬁned as
Fig. 1 Overall study design
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123fasting plasma glucose C7.0 mmol/l, or current pharma-
cological treatment of diabetes, or self-reported history of
diabetes [15].
Retrieval of end-points
All study participants were followed from the baseline
examination until the death, emigration from Sweden, or
31 December 2006. Authors applied linkage of the unique
10-digit personal identiﬁcation number with the Swedish
National Cause of Death Register. The primary diagnosis
retrieved from the register was considered valid for the
speciﬁc cause of death as applied in previous studies [13,
16]. The International Classiﬁcation of Diseases (ICD)-8
codes were converted to ICD-9 codes, if applicable. The
causes of deaths were classiﬁed into CVD (ICD-9 codes
390–459, ICD-10; I00–I99), cancer (ICD-9 codes 140–239,
ICD-10; C00–C99), injury (ICD-9 codes 800–999, ICD-10;
V, W, X, Y), respiratory diseases (ICD-9 codes 460–519,
ICD-10; J), digestive system diseases (ICD-9 codes
520–579, ICD-10; K), neurological diseases (ICD-9 codes
320–389, ICD-10; G, H), and other causes of death. Death
due to ischemic heart disease was deﬁned as 410–414 or
I20–I22 according to ICD-9 and ICD-10, whereas death
due to cerebrovascular disease as 430–438, or I60–I69,
respectively.
Those who emigrated from Sweden before 31 December
2006, and had been event-free at the time of emigration
(n = 624, 1.9%), were censored at the date of emigration.
The mean follow-up time was 23.5 ± 6.2 years.
Statistical analysis
The relationship between OH, quartiles of DSBP and all-
cause mortality was assessed by the Kaplan–Meier method
and the log-rank test. The hazards risks for total and cause-
speciﬁc mortality according to OH status, or, alternatively,
by quartiles of DSBP were investigated using Cox pro-
portional hazards models. The proportional hazards
assumption was assessed graphically in a univariate model.
Two Cox regression models were applied: a basic Model 1
adjusted for age and gender, and a more comprehensive
Model 2 adjusted additionally for traditional risk factors for
OH and mortality: BMI, SBP, resting heart rate, antihy-
pertensive treatment, diabetes, total cholesterol and current
smoking [8]. In Model 2, authors excluded individuals with
missing data on BMI (n = 5) and total cholesterol
(n = 58). In additional adjustment, alcohol intake and
socioeconomic status were entered into the Model 2, and
analyses were repeated. Those with the unspeciﬁed socio-
economic status were excluded (n = 2,512), of these
10.4% were OH positive. Finally, authors performed Cox
regression analysis according to Model 1 and 2 on a subset
of MPP cohort (n = 6,109), which was rescreened after
approximately 6 years from baseline, including orthostatic
BP measurements (Fig. 1).
Potential interactions between OH and age or gender on
cause-speciﬁc mortality were evaluated by including
interaction terms in the multivariate model. All analyses
were performed using SPSS statistical software version
17.0 for Windows (SPSS Inc., Chicago, IL). All tests were
two-sided whereby P\0.05 was considered statistically
signiﬁcant for non-interaction terms, and P\0.10 for
interaction terms.
Results
Out of 32,068 individuals included in the present study,
1,943 (6.1%) met the diagnostic criteria of OH at baseline,
whereas 570 among 5,805 participants (9.8%) were found
to have OH during rescreening program. The baseline
characteristics of MPP cohort and the rescreened subset of
study population according to OH status were published
previously [8, 17]. As can be seen in Table 1, nearly one
third of study participants (Q2SBP, n = 10,123) demon-
strated a neutral orthostatic SBP response (i.e. no differ-
ence between supine and standing SBP), which resulted in
a disproportional partition of study sample into quartiles.
Those with hypotensive response (Q4SBP) were older, had
higher SBP and DBP, and higher proportions of women,
patients with diabetes and of those receiving antihyper-
tensive treatment. Figure 2 illustrates the cumulative all-
cause mortality during follow-up by quartiles of DSBP.
The Kaplan–Meier curves for the total mortality by OH
status corresponded to authors’ previous publication [8]
and were not shown (log-rank test, P B 0.001 for both). As
can be seen in Table 2, total mortality and mortality rate
were higher among those with as compared to those
without OH (14.1 vs. 9.1 deaths per 1,000 person-years). A
similar trend was observed across the quartiles of DSBP
(Q1SBP vs. Q4SBP: 8.1 vs. 12.3 deaths per 1,000 person-
years). As shown in Table 3, OH was predictive of four
speciﬁc causes of death in the Cox regression analysis
according to Model 1: CVD, injuries, respiratory and
neurological diseases. However, after further adjustment
for traditional risk factors (Model 2), only death due to
injury and neurological disease (in 16/20 cases diagnosed
as neurodegenerative disease) were predicted by OH. There
were two potential interactions between OH and age: on
death due to cancer (P = 0.001) and neurological disease
(P = 0.082). In a subgroup analysis authors found that
cancer-related mortality was signiﬁcantly increased in the
youngest stratum of study population (\42 years,
n = 9,357; HR, 1.66; 95% CI: 1.03–2.69, P = 0.039),
whereas risk of death due to neurological disease was
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123highest among the oldest study participants ([48 years,
n = 11,830; HR, 2.87, 95% CI: 1.64–5.08, P\0.001).
There was no potential interaction between OH and gender.
The main mortality trends found among those with OH
were conﬁrmed by stratiﬁcation of study participants
according to quartiles of postural BP response. As pre-
sented in Table 4, subset of population characterized by a
pronounced hypotensive response (Q4SBP, -13.7 ± 5.7
mmHg) had highest total mortality (HR, 1.13; 95% CI:
1.06–1.21). Risk of death caused by both injury and neu-
rological disease increased across the quartiles of DSBP,
being for the latter and for Q4SBP similar to that observed
among OH positive individuals (HR, 1.84; 95% CI: 1.20–
2.82 vs. 2.21; 1.39–3.51, respectively). In contrast,
those with hypertensive BP response (Q1SBP, ?8.5 ±
4.7 mmHg) had signiﬁcantly lower risk of death due to
respiratory disease (mainly represented by chronic
obstructive pulmonary disease) as compared to the other
quartiles of DSBP (Q4SBP vs. Q1SBP: HR, 1.53; 95% CI:
1.14–2.04). Moreover, authors noted a U-shaped risk curve
for cerebrovascular death with a nadir in the 3rd quartile of
DSBP (Q3SBP, -5.0 ± 0.1 mmHg; HR, 0.75; 95% CI:
0.54–1.03; P for linear trend = 0.021). There was one
potential interaction between quartiles of DSBP and age:
on cancer-related mortality (P = 0.031). In a subgroup
analysis, the pronounced hypotensive response was pre-
dictive of cancer-related mortality within the middle age
stratum (42–48 years, n = 10,881, Q4SBP vs. Q1SBP: HR,
1.25; 95% CI: 1.04–1.49; P for linear trend 0.067), whereas
among youngest study participants (B42 years) the highest
risk was observed in the 3rd but not 4th quartile (Q3SBP vs.
Q1SBP: HR, 1.23; 95% CI: 0.91–1.67, and Q4SBP vs.
Q1SBP: HR, 0.96; 95% CI: 0.67–1.39; P for linear trend
0.69).
Additional adjustments for socioeconomic status and
alcohol intake did not change the main results and only
slightly attenuated mortality risk associated with OH
(injuries, HR: 1.74; 95% CI: 1.20–2.53; neurological, 2.00,
1.18–3.36), and Q4SBP (injuries, HR: 1.21; 95% CI:
0.89–1.64; neurological, 1.68; 1.05–2.69, respiratory, 1.46;
1.05–2.04).
As shown in Table 5, results obtained from the sub-
sidiary analysis on the rescreened subset of MPP cohort
Table 1 Baseline characteristics of participants of the Malmo ¨ Preventive Project according to quartiles of postural systolic blood pressure
response
Characteristics All
n = 32,068
1st quartile
(Q1SBP)
n = 9,543
2nd Quartile
(Q2SBP)
n = 10,123
3rd Quartile
(Q3SBP)
n = 5,917
4th Quartile
(Q4SBP)
n = 6,485
Postural SBP response (mmHg) -1.2 ± 8.7 ?8.5 ± 4.7 0.0 ± 0.1 -5.0 ± 0.1 -13.7 ± 5.7
Age (years) 45.5 ± 7.4 44.0 ± 7.4 45.1 ± 7.5 46.1 ± 7.1 47.8 ± 7.0
Gender (male, %) 69.0 75.8 70.0 64.8 61.2
BMI (kg/m
2) 24.6 ± 3.6 24.5 ± 3.4 24.6 ± 3.6 24.6 ± 3.7 24.6 ± 3.8
Current smoker (%) 44.8 45.1 44.4 45.1 44.7
Supine SBP (mmHg) 126.3 ± 15.5 122.6 ± 14.3 125.5 ± 14.6 126.3 ± 14.4 133.2 ± 17.1
Supine DBP (mmHg) 84.3 ± 9.6 83.6 ± 9.6 84.1 ± 9.4 84.0 ± 9.3 86.0 ± 10.1
Heart rate (beats/min) 67.5 ± 9.8 66.9 ± 9.7 67.2 ± 9.7 67.8 ± 9.5 68.5 ± 10.1
Antihypertensive treatment (%) 5.2 3.6 4.7 4.7 8.9
Diabetes (%) 4.6 3.9 4.4 4.6 6.1
Total cholesterol (mmol/l) 5.7 ± 1.1 5.6 ± 1.1 5.6 ± 1.1 5.7 ± 1.1 5.8 ± 1.1
Problematic drinking behavior (%) 21.6 23.6 22.3 20.1 19.1
Low socioeconomic status (%) 46.2 44.5 46.5 45.9 48.8
SBP systolic blood pressure, DBP diastolic blood pressure, BMI body-mass index. Data are presented as proportions or mean ± SD
Fig. 2 Cumulative all-cause mortality during follow-up according to
quartiles of postural systolic blood pressure response (DSBP)a t
baseline among 32,068 participants of the Malmo ¨ Preventive Project.
Log-rank test, P\0.001
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123were essentially consistent with the main ﬁndings. How-
ever, the relative mortality risk conferred by presence of
hypotensive response at rescreening (i.e. OH positive or
Q4SBP) was in general higher than that at baseline, both for
all and speciﬁc causes of death. Furthermore, the hypo-
tensive response at rescreening independently predicted
higher cardiovascular mortality, in contrast to the baseline
status (OH positive, HR, 1.54; 95% CI: 1.24–1.89;
P B 0.001, and Q4SBP vs. Q1SBP: HR, 1.27; 95% CI:
1.02–1.57, P for linear trend = 0.021, respectively).
Discussion
Orthostatic haemodynamic impairment is generally regar-
dedasatroublesomeclinicalcondition,especiallyinelderly,
chronically ill, neurological, and polymorbid patients [18–
20], and surprisingly little is known about its prevalence and
consequences in general population. In particular, associa-
tion between OH and the cause-speciﬁc mortality remains
largely unexplored. To our knowledge, this is the ﬁrst study
to report that injuries and neurological diseases may be eti-
ologically related to the increased mortality among middle-
aged individuals with often asymptomatic OH. Moreover, a
statistical evidence could be also demonstrated for respira-
tory diseases (for the quartile with the most pronounced
hypotensive SBP response) and cancer (in younger individ-
ualsaged\48 years).Themainﬁndingsarediscussedbelow
in regard to speciﬁc diagnostic categories:
Cardiovascular disease
The association between prevalent OH and long-term
mortality due to CVD (or ischemic heart disease only),
reported previously by other authors in the ARIC cohort
[6], was remarkably attenuated after adjustment for con-
ventional risk factors. These results were most probably an
effect of a strong correlation between OH and CV risk
factors, which in turn predict increased mortality mediated
by CVD. Except for total cholesterol, all other covariates
entered into the more comprehensive model are known to
Table 2 All-cause mortality in
relation to presence or absence
of orthostatic hypotension (OH)
and quartiles of orthostatic
systolic blood pressure response
(DSBP) among 32,068
participants of the Malmo ¨
Preventive Project
Subgroups according
to OH status
Number of
individuals at risk
Total
mortality (%)
No of deaths/
z1,000 person-years
All 32,068 7,145 (22.3) 9.4
OH negative 30,125 6,540 (21.7) 9.1
OH positive 1,943 605 (31.1) 14.1
1st quartile of DSBP 9,543 1,886 (19.8) 8.1
2nd quartile of DSBP 10,123 2,154 (21.3) 8.9
3rd quartile of DSBP 5,917 1,299 (22.0) 9.3
4th quartile of DSBP 6,485 1,806 (27.8) 12.3
Table 3 Association between orthostatic hypotension (OH) and
speciﬁc causes of death among 32,068 participants of the Malmo ¨
Preventive Project
Causes of death
No of deaths
OH neg/pos
Model 1
Hazard ratio
[95% CI]
Model 2
Hazard ratio
[95% CI]
All causes
6,540/605
1.30
[1.19–1.41]
P\0.001
1.11
[1.02–1.21]
P = 0.018
Cancer
2,524/198
1.08
[0.93–1.25]
P = 0.32
1.01
[0.87–1.17]
P = 0.93
Cardiovascular
2,394/244
1.36
[1.19–1.56]
P\0.001
1.02
[0.89–1.17]
P = 0.78
IHD
1,571/161
1.40
[1.19–1.65]
P\0.001
1.03
[0.87–1.22]
P = 0.74
Cerebrovascular
376/31
1.02
[0.71–1.48]
P = 0.91
0.79
[0.54–1.16]
P = 0.23
Injuries
418/46
1.88
[1.39–2.56]
P\0.001
1.88
[1.37–2.57]
P < 0.001
Respiratory
369/41
1.50
[1.08–2.08]
P = 0.015
1.30
[0.94–1.82]
P = 0.12
Digestive
235/18
1.23
[0.76–1.99]
P = 0.41
1.01
[0.62–1.65]
P = 0.98
Neurological
145/22
2.09
[1.32–3.28]
P = 0.002
2.21
[1.39–3.51]
P = 0.001
Other causes
455/36
1.22
[0.87–1.72]
P = 0.25
1.07
[0.75–1.51]
P = 0.72
Model 1: adjusted for age and gender; Model 2: adjusted for age,
gender, body mass index, systolic blood pressure, resting heart rate,
antihypertensive treatment, diabetes, total cholesterol, and current
smoking. IHD ischaemic heart disease
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123Table 4 Association between quartiles of postural systolic blood pressure response (DSBP) and cause-speciﬁc mortality among 32,068 par-
ticipants of the Malmo ¨ Preventive Project
Causes of death
No of deaths
Hazard ratio
[95% CI]
Quartiles of DSBP (mmHg)*
Q1SBP

?8.5 ± 4.7
n = 9,543
(P linear trend)
Q2SBP
0.0 ± 0.1
n = 10,123
Q3SBP
-5.0 ± 0.1
n = 5,917
Q4SBP
-13.7 ± 5.7
n = 6,485
All causes n = 1,886 n = 2,154 n = 1,299 n = 1,806
Model 1 1.00
\0.001
1.06
[1.00–1.13]
1.06
[1.00–1.14]
1.30
[1.21–1.38]
Model 2 1.00
0.002
1.03
[0.97–1.10]
1.00
[0.93–1.08]
1.13
[1.06–1.21]
Cancer n = 741 n = 843 n = 510 n = 628
Model 1 1.00
0.34
1.04
[0.94–1.15]
1.04
[0.93–1.16]
1.11
[0.99–1.23]
Model 2 1.00
0.56
1.02
[0.93–1.13]
1.00
[0.89–1.12]
1.04
[0.93–1.17]
Cardiovascular n = 692 n = 745 n = 472 n = 729
Model 1 1.00
\0.001
0.99
[0.90–1.10]
1.06
[0.94–1.19]
1.39
[1.25–1.54]
Model 2 1.00
0.12
0.95
[0.86–1.06]
0.96
[0.86–1.08]
1.09
[0.98–1.21]
IHD n = 468 n = 503 n = 323 n = 474
Model 1 1.00
\0.001
1.00
[0.88–1.14]
1.08
[0.94–1.25]
1.35
[1.18–1.54]
Model 2 1.00
0.36
0.95
[0.84–1.08]
0.99
[0.86–1.14]
1.06
[0.92–1.21]
Cerebrovascular n = 107 n = 113 n = 59 n = 128
Model 1 1.00
\0.001
0.94
[0.72–1.22]
0.81
[0.59–1.11]
1.44
[1.11–1.87]
Model 2 1.00
0.021
0.91
[0.69–1.18]
0.75
[0.54–1.03]
1.20
[0.91–1.57]
Injuries n = 131 n = 137 n = 93 n = 103
Model 1 1.00
0.026
1.03
[0.81–1.31]
1.23
[0.94–1.60]
1.30
[1.00–1.69]
Model 2 1.00
0.028
1.04
[0.82–1.33]
1.21
[0.93–1.59]
1.32
[1.00–1.72]
Respiratory n = 89 n = 125 n = 79 n = 117
Model 1 1.00
0.002
1.30
[0.99–1.71]
1.35
[1.00–1.83]
1.73
[1.30–2.28]
Model 2 1.00
0.009
1.30
[0.99–1.71]
1.26
[0.92–1.71]
1.53
[1.14–2.04]
Digestive n = 65 n = 97 n = 31 n = 60
Model 1 1.00
0.36
1.44
[1.05–1.97]
0.79
[0.51–1.21]
1.42
[0.99–2.03]
Model 2 1.00
0.89
1.43
[1.04–1.97]
0.75
[0.49–1.16]
1.25
[0.86–1.80]
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123be independent determinants of both OH [8] and cardio-
vascular morbidity, such as myocardial infarction and
stroke [21, 22]. Taking into account conventional risk
factors might thus efﬁciently explain why individuals with
OH were prematurely affected by CVD and died. However,
in the rescreened subset of study population, characterized
by similar mean age as that in the ARIC cohort (53 vs.
54 years) the hypotensive orthostatic response was inde-
pendently predictive of cardiovascular mortality. Conse-
quently, presence of impaired orthostatic BP response in a
more advanced age may be a stronger cardiovascular risk
factor than the same phenomenon among relatively
younger individuals.
Another important ﬁnding in this diagnostic group was a
trend toward U-shaped curve for quartiles of DSBP and
cerebrovascular mortality, in concordance with previous
reports [23, 24]. Thus, a neutral or a slightly hypotensive
SBP response during orthostatic challenge may play a
protective role against cerebrovascular lesion.
Injuries
One of the most consistent ﬁndings in this study was the
relationship between OH and injury-related deaths. Hae-
modynamic impairment during orthostasis is a well-known
risk factor of traumatic falls among neurologically ill and
elderly patients [2, 25]. The mean age of the studied pop-
ulation was, however, only about 45 years. We propose
that some of injuries were provoked by a temporary
impairment of the cerebral circulation when the haemo-
dynamic reserve between minimal BP needed for mainte-
nance of cerebral perfusion (usually SBP C 60–70 mm Hg)
[26] and the actual value of BP was compressed by the
orthostatic drop. Some patients with asymptomatic
impairment of orthostatic BP regulation may not be aware
of the problem until the ﬁrst episode of sudden onset diz-
ziness or syncope occurs. Interestingly, the best predictor
of injury-related death was the standard OH deﬁnition,
which suggests that the magnitude of BP fall is a crucial
factor behind this association.
Neurological diseases
Neurological etiology was found to be another factor
associated with increased mortality in individuals with OH
and a pronounced postural decrease of SBP (Q4SBP). This
ﬁnding is not at all surprising taking into account a strong
etiological relationship between OH and neurodegenerative
diseases, such as Parkinson’s disease and primary auto-
nomic failure [27]. Thus, in some participants, subclinical
neurodegenerative process may have already been present
at baseline and the orthostatic challenge was sensitive
enough to detect the accompanying autonomic dysfunction.
Notably, the risk of fatal neurological disease was higher
among older participants (C48 years), and in the
rescreened subset of cohort, conﬁrming that postural BP
drop is more often related to neurogenic OH with
advancing older [28].
Respiratory diseases
Association between postural BP response and mortality
due to a respiratory disease (mainly chronic obstructive
pulmonary disease, COPD) was a surprising ﬁnding. We
Table 4 continued
Causes of death
No of deaths
Hazard ratio
[95% CI]
Quartiles of DSBP (mmHg)*
Q1SBP

?8.5 ± 4.7
n = 9,543
(P linear trend)
Q2SBP
0.0 ± 0.1
n = 10,123
Q3SBP
-5.0 ± 0.1
n = 5,917
Q4SBP
-13.7 ± 5.7
n = 6,485
Neurological n = 40 n = 44 n = 30 n = 53
Model 1 1.00
0.025
1.01
[0.66–1.55]
1.11
[0.69–1.79]
1.72
[1.13–2.61]
Model 2 1.00
0.005
1.03
[0.67–1.58]
1.13
[0.70–1.82]
1.84
[1.20–2.82]
Other causes n = 128 n = 163 n = 84 n = 116
Model 1 1.00
0.069
1.23
[0.97–1.55]
1.06
[0.80–1.39]
1.34
[1.04–1.73]
Model 2 1.00
0.42
1.20
[0.95–1.51]
1.02
[0.77–1.34]
1.18
[0.91–1.54]
* Mean ± standard deviation;
 Reference quartile; Model 1, adjusted for age and gender; Model 2, adjusted for age, gender, body-mass index,
supine systolic blood pressure, resting heart rate, antihypertensive treatment, diabetes, current smoking and total cholesterol. IHD ischaemic heart
disease
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123Table 5 Association between orthostatic hypotension, quartiles of systolic blood pressure response (DSBP) and cause-speciﬁc mortality among
5,805 participants of the rescreening program within Malmo ¨ Preventive Project
Causes of death
Hazard ratio
[95% CI]
OH status Quartiles of DSBP (mmHg)*
Negative
(reference)
n = 5,235
(P value)
Positive
n = 570
Q1SBP

?8.7 ± 4.6
n = 1,300
(P linear trend)
Q2SBP
0.0 ± 0.0
n = 1,713
Q3SBP
-5.0 ± 0.1
n = 1,024
Q4SBP
-14.2 ± 6.0
n = 1,768
All causes n = 1,537 n = 232 n = 338 n = 496 n = 295 n = 640
Model 1 1.00
\0.001
1.47
[1.28–1.68]
1.00
\0.001
1.12
[0.98–1.29]
1.11
[0.95–1.30]
1.40
[1.23–1.60]
Model 2 1.00
0.001
1.29
[1.12–1.48]
1.00
0.002
1.11
[0.97–1.28]
1.08
[0.92–1.26]
1.25
[1.09–1.43]
Cancer n = 599 n = 66 n = 141 n = 190 n = 124 n = 210
Model 1 1.00
0.59
1.07
[0.83–1.38]
1.00
0.30
1.03
[0.83–1.28]
1.12
[0.88–1.43]
1.10
[0.89–1.37]
Model 2 1.00
0.82
1.03
[0.80–1.34]
1.00
0.41
1.05
[0.84–1.30]
1.12
[0.88–1.43]
1.09
[0.87–1.35]
Cardiovascular n = 582 n = 113 n = 132 n = 184 n = 97 n = 282
Model 1 1.00
\0.001
1.88
[1.53–2.29]
1.00
\0.001
1.07
[0.85–1.33]
0.93
[0.72–1.21]
1.56
[1.27–1.92]
Model 2 1.00
<0.001
1.54
[1.24–1.89]
1.00
0.021
1.01
[0.81–1.26]
0.87
[0.67–1.14]
1.27
[1.02–1.57]
IHD n = 387 n = 82 n = 80 n = 128 n = 64 n = 197
Model 1 1.00
\0.001
2.06
[1.62–2.61]
1.00
\0.001
1.23
[0.93–1.62]
1.02
[0.73–1.41]
1.80
[1.39–2.34]
Model 2 1.00
<0.001
1.65
[1.29–2.12]
1.00
0.011
1.15
[0.87–1.53]
0.97
[0.69–1.34]
1.43
[1.10–1.87]
Cerebrovascular n = 94 n = 11 n = 26 n = 25 n = 17 n = 37
Model 1 1.00
0.72
1.12
[0.60–2.09]
1.00
0.67
0.74
[0.43–1.27]
0.83
[0.45–1.52]
1.03
[0.62–1.70]
Model 2 1.00
0.77
0.91
[0.48–1.73]
1.00
0.71
0.71
[0.41–1.23]
0.75
[0.40–1.39]
0.84
[0.50–1.42]
Injuries n = 59 n = 12 n = 10 n = 16 n = 16 n = 29
Model 1 1.00
0.034
1.96
[1.05–3.65]
1.00
0.013
1.23
[0.56–2.71]
2.06
[0.93–4.53]
2.16
[1.05–4.44]
Model 2 1.00
0.066
1.82
[0.96–3.46]
1.00
0.03
1.20
[0.54–2.65]
1.94
[0.88–4.29]
1.98
[0.95–4.15]
Respiratory n = 96 n = 23 n = 17 n = 25 n = 24 n = 53
Model 1 1.00
\0.001
2.30
[1.46–3.62]
1.00
\0.001
1.12
[0.60–2.07]
1.78
[0.95–3.31]
2.28
[1.32–3.94]
Model 2 1.00
0.024
1.73
[1.07–2.78]
1.00
0.005
1.22
[0.65–2.28]
1.80
[0.95–3.39]
2.03
[1.14–3.60]
Digestive n = 42 n = 6 n = 10 n = 16 n = 8 n = 14
Model 1 1.00
0.41
1.44
[0.61–3.39]
1.00
0.95
1.23
[0.56–2.72]
1.04
[0.41–2.64]
1.10
[0.49–2.50]
Model 2 1.00
0.66
1.22
[0.50–2.97]
1.00
0.83
1.15
[0.51–2.56]
1.03
[0.41–2.63]
0.96
[0.42–2.23]
Neurological n = 39 n = 4 n = 3 n = 14 n = 8 n = 18
Model 1 1.00
0.97
1.02
[0.37–2.86]
1.00
0.022
3.60
[1.03–12.52]
3.43
[0.91–12.94]
4.59
[1.35–15.62]
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123know that smoking is associated with OH [8]. However,
after adjustment for current smoking the predictive role of
postural SBP and MAP response remained statistically
signiﬁcant. These results suggest that autonomic dysfunc-
tion is associated with a higher risk of developing terminal
lung disease. Among the proposed predictors of increased
mortality in COPD there are no parameters that can be
directly linked to OH or autonomic dysfunction [29]. On
the other hand, some authors claim that spirometry alone is
not a good predictor of mortality in COPD, and other
parameters, such as low BMI, dyspnoea, and exercise
capacity are often included in the mortality risk score
systems [30]. Interestingly, low BMI is also an independent
determinant of OH [8]. Moreover, in patients with COPD,
cardiac autonomic dysfunction (reduced heart rate vari-
ability) was found to be correlated with lower BMI,
reduced level of physical activity in daily life, and
impairment of respiratory and peripheral muscle condition
[31]. In orthostatic blood pressure dysregulation a similar
pattern has been observed: a sympathetic hyperactivity
associated with reduced variability of the parasympathetic
nervous system [32]. Thus, the common pathway for the
orthostatic blood pressure drop and increased risk of
respiratory-related mortality might be a chronically altered
autonomic function signaled by lower BMI, worse exercise
tolerance, and more subtle markers, such as reduced heart
rate variability. Unfortunately, given the available cohort
data, authors were not able to conﬁrm this hypothesis.
Cancer
The relevance of the association between cancer-related
mortality and hypotensive BP response in younger adults is
unclear and might suggest that haemodynamic postural
impairment (and subclinical autonomic disorders), if acting
long enough, can favor carcinogenesis through unspeciﬁed
biologically active substances, whose plasma or tissue
activity is altered by a chronically increased sympathetic
tonus and reduced parasympathetic reactivity. However,
such hypothesis would require further studies to be
conﬁrmed.
Strengths and limitations of the study
Strength of this study lies in a large number and similar
ethnic background of the studied cohort, long follow-up,
and access to an end-point register with a high case
ascertainment. The main limitation is the fact that standing
blood pressure was recorded between the 1st and 3rd min
after assuming an upright position and we may have,
therefore, missed those with initial (\1 min) [33] and
delayed ([3 min) orthostatic hypotension [34]. Moreover,
OH was assessed in the whole cohort only once between
baseline and end-point.
Conclusions
Among middle-aged individuals the increased risk of
mortality independently conferred by impairment of
orthostatic blood pressure regulation is associated with
injuries, neurodegenerative, and respiratory diseases. Fur-
thermore, both increase and pronounced decrease of sys-
tolic blood pressure during early orthostasis indicate a
higher risk of death due to cerebrovascular disease,
whereas blood pressure decrease on standing in the
advanced age seems to be also an independent predictor of
higher cardiovascular mortality.
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Table 5 continued
Causes of death
Hazard ratio
[95% CI]
OH status Quartiles of DSBP (mmHg)*
Negative
(reference)
n = 5,235
(P value)
Positive
n = 570
Q1SBP

?8.7 ± 4.6
n = 1,300
(P linear trend)
Q2SBP
0.0 ± 0.0
n = 1,713
Q3SBP
-5.0 ± 0.1
n = 1,024
Q4SBP
-14.2 ± 6.0
n = 1,768
Model 2 1.00
0.85
1.11
[0.39–3.16]
1.00
0.008
3.68
[1.06–12.85]
3.69
[0.98–13.97]
5.46
[1.57–18.92]
Other causes n = 120 n = 8 n = 25 n = 51 n = 18 n = 34
Model 1 1.00
0.26
0.66
[0.32–1.35]
1.00
0.44
1.56
[0.97–2.53]
0.92
[0.50–1.69]
1.02
[0.61–1.71]
Model 2 1.00
0.11
0.56
[0.27–1.15]
1.00
0.17
1.55
[0.96–2.51]
0.88
[0.48–1.62]
0.88
[0.52–1.49]
* Mean ± standard deviation;
 Reference quartile; Model 1, adjusted for age and gender; Model 2, adjusted for age, gender, body-mass index,
supine systolic blood pressure, resting heart rate, antihypertensive treatment, diabetes, current smoking and total cholesterol
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